Q2 2024 AxoGen Inc Earnings Call Transcript
Key Points
- Axogen Inc (AXGN) reported a strong second quarter with a 25.6% increase in revenue compared to the previous year.
- The company achieved a positive adjusted EBITDA of $5.6 million, a significant improvement from a loss of $0.2 million in the prior year.
- Axogen Inc (AXGN) raised its revenue guidance for the full year 2024, reflecting confidence in continued growth.
- The company successfully launched Avive+ Soft Tissue Matrix, receiving positive feedback from surgeons.
- Axogen Inc (AXGN) expanded its core accounts to 412, up from 347 in the previous year, indicating successful market penetration.
- The company faced startup costs and challenges with its new processing facility, impacting gross margins.
- Gross margin decreased to 73.8% from 77.7% in the same period last year due to higher relative costs from the new facility.
- Despite improvements, Axogen Inc (AXGN) reported a net loss of $1.9 million for the quarter.
- The transition to the new facility resulted in higher product costs, which may continue to affect margins in the near term.
- The company anticipates potential deceleration in growth in the second half of the year, reflecting a cautious outlook.
Greetings, and welcome to the Axogen, Inc., reports 2024 second-quarter financial results call. (Operator Instructions) As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Harold Tamayo, Vice President of Finance and Investor Relations. Thank you, Harold. You may begin.
Thank you, Maria. Good morning, everyone. Joining me on today's call is Karen Zaderej, Axogen's Chairman, Chief Executive Officer, and President; and Nir Naor, Chief Financial Officer. Karen will discuss the second quarter of 2024 financial results, and Nir will provide an analysis of our financial performance and guidance and discuss our outlook for the year, followed by a question-and-answer session.
Today's call is being broadcast live via webcast, which is available on the Investors section of the Axogen website. Following the end of the live call, a replay will be available in the Investors section of the company's website at
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
